CDKN2B and cervical cancer: For example, research conducted by Zhu et al. revealed that the mRNA expression of the candidate lncRNA CDKN2B-AS1 was significantly upregulated in cervical cancer cells, whereas the expression of miR-181a-5p was notably downregulated in cervical cancer cells.